Michael J. Bennett Ph.D., FRCPath, DABCC, FACB, is a Professor of Pathology and
Laboratory Medicine at the University of Pennsylvania and Chief of Laboratory
Medicine at The Children’s Hospital of Philadelphia. He holds the Evelyn Willing
Bromley Endowed Chair in Clinical Laboratories and Pathology. He obtained his Ph.D.
at the University of Sheffield School of Medicine, UK in the field of Medical
Dr Bennett is past chair of the Texas section and of the Pediatric and Maternal-Fetal and proteomics and metabolomics Divisions of AACC. He is Past President of the National Academy of Clinical Biochemistry (NACB), the immediate past-treasurer of AACC and current AACC President.
Dr Bennett’s research activities include the use of mass spectrometry in the investigation of inborn errors of mitochondrial energy metabolism with a special emphasis on disorders of fatty acid metabolism. He was amongst the first to describe the fatal clinical phenotype and subsequently the first to identify neonatal metabolite abnormalities in medium-chain acyl-CoA dehydrogenase (MCAD) deficiency. These observations led eventually to the present expansion in expanded newborn screening by tandem mass spectrometry. Dr. Bennett has also recently described a novel mitochondrial matrix protein complex that brings together pathways of fatty acid oxidation, ureagenesis, oxidative phosphorylation and transamination.
Dr Bennett has published over 290 peer reviewed original articles in the field of pediatric clinical chemistry and biochemical genetics and sits on the editorial boards of 4 major journals in the field including Clinical Chemistry where he is an associate editor, Journal of Inherited Metabolic Diseases, Molecular Genetics and Metabolism and Annals of Clinical Biochemistry. He has also authored over 45 book Chapters and review articles. Dr. Bennett has lectured extensively on the subjects of metabolic diseases and pediatric clinical chemistry.